- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Artemisinin Antimalarial Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Artemisinin Antimalarial Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Prevention accounting for % of the Artemisinin Antimalarial Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Artesunate segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Artemisinin Antimalarial Drugs include Novartis, Sanofi, Ajanta, Cipla, and Ipca, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Artemisinin Antimalarial Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Artesunate
Dihydroartemisinin
Artemether
Market segment by Application can be divided into
Prevention
Treatment
Other
The key market players for global Artemisinin Antimalarial Drugs market are listed below:
Novartis
Sanofi
Ajanta
Cipla
Ipca
Guilin Medicine
GlaxoSmithKline
Mylan Labs
Roche
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Artemisinin Antimalarial Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Artemisinin Antimalarial Drugs, with price, sales, revenue and global market share of Artemisinin Antimalarial Drugs from 2019 to 2022.
Chapter 3, the Artemisinin Antimalarial Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Artemisinin Antimalarial Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Artemisinin Antimalarial Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artemisinin Antimalarial Drugs.
Chapter 13, 14, and 15, to describe Artemisinin Antimalarial Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Artemisinin Antimalarial Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Artemisinin Antimalarial Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Artesunate
1.2.3 Dihydroartemisinin
1.2.4 Artemether
1.3 Market Analysis by Application
1.3.1 Overview: Global Artemisinin Antimalarial Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Prevention
1.3.3 Treatment
1.3.4 Other
1.4 Global Artemisinin Antimalarial Drugs Market Size & Forecast
1.4.1 Global Artemisinin Antimalarial Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Artemisinin Antimalarial Drugs Sales in Volume (2017-2028)
1.4.3 Global Artemisinin Antimalarial Drugs Price (2017-2028)
1.5 Global Artemisinin Antimalarial Drugs Production Capacity Analysis
1.5.1 Global Artemisinin Antimalarial Drugs Total Production Capacity (2017-2028)
1.5.2 Global Artemisinin Antimalarial Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Artemisinin Antimalarial Drugs Market Drivers
1.6.2 Artemisinin Antimalarial Drugs Market Restraints
1.6.3 Artemisinin Antimalarial Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Artemisinin Antimalarial Drugs Product and Services
2.1.4 Novartis Artemisinin Antimalarial Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Artemisinin Antimalarial Drugs Product and Services
2.2.4 Sanofi Artemisinin Antimalarial Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Ajanta
2.3.1 Ajanta Details
2.3.2 Ajanta Major Business
2.3.3 Ajanta Artemisinin Antimalarial Drugs Product and Services
2.3.4 Ajanta Artemisinin Antimalarial Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Cipla
2.4.1 Cipla Details
2.4.2 Cipla Major Business
2.4.3 Cipla Artemisinin Antimalarial Drugs Product and Services
2.4.4 Cipla Artemisinin Antimalarial Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Ipca
2.5.1 Ipca Details
2.5.2 Ipca Major Business
2.5.3 Ipca Artemisinin Antimalarial Drugs Product and Services
2.5.4 Ipca Artemisinin Antimalarial Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Guilin Medicine
2.6.1 Guilin Medicine Details
2.6.2 Guilin Medicine Major Business
2.6.3 Guilin Medicine Artemisinin Antimalarial Drugs Product and Services
2.6.4 Guilin Medicine Artemisinin Antimalarial Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business
2.7.3 GlaxoSmithKline Artemisinin Antimalarial Drugs Product and Services
2.7.4 GlaxoSmithKline Artemisinin Antimalarial Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Mylan Labs
2.8.1 Mylan Labs Details
2.8.2 Mylan Labs Major Business
2.8.3 Mylan Labs Artemisinin Antimalarial Drugs Product and Services
2.8.4 Mylan Labs Artemisinin Antimalarial Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business
2.9.3 Roche Artemisinin Antimalarial Drugs Product and Services
2.9.4 Roche Artemisinin Antimalarial Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Artemisinin Antimalarial Drugs Breakdown Data by Manufacturer
3.1 Global Artemisinin Antimalarial Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Artemisinin Antimalarial Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Artemisinin Antimalarial Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Artemisinin Antimalarial Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Artemisinin Antimalarial Drugs Manufacturer Market Share in 2021
3.5 Global Artemisinin Antimalarial Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Artemisinin Antimalarial Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Artemisinin Antimalarial Drugs Market Size by Region
4.1.1 Global Artemisinin Antimalarial Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Artemisinin Antimalarial Drugs Revenue by Region (2017-2028)
4.2 North America Artemisinin Antimalarial Drugs Revenue (2017-2028)
4.3 Europe Artemisinin Antimalarial Drugs Revenue (2017-2028)
4.4 Asia-Pacific Artemisinin Antimalarial Drugs Revenue (2017-2028)
4.5 South America Artemisinin Antimalarial Drugs Revenue (2017-2028)
4.6 Middle East and Africa Artemisinin Antimalarial Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Artemisinin Antimalarial Drugs Sales in Volume by Type (2017-2028)
5.2 Global Artemisinin Antimalarial Drugs Revenue by Type (2017-2028)
5.3 Global Artemisinin Antimalarial Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Artemisinin Antimalarial Drugs Sales in Volume by Application (2017-2028)
6.2 Global Artemisinin Antimalarial Drugs Revenue by Application (2017-2028)
6.3 Global Artemisinin Antimalarial Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Artemisinin Antimalarial Drugs Sales by Type (2017-2028)
7.2 North America Artemisinin Antimalarial Drugs Sales by Application (2017-2028)
7.3 North America Artemisinin Antimalarial Drugs Market Size by Country
7.3.1 North America Artemisinin Antimalarial Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Artemisinin Antimalarial Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Artemisinin Antimalarial Drugs Sales by Type (2017-2028)
8.2 Europe Artemisinin Antimalarial Drugs Sales by Application (2017-2028)
8.3 Europe Artemisinin Antimalarial Drugs Market Size by Country
8.3.1 Europe Artemisinin Antimalarial Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Artemisinin Antimalarial Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Artemisinin Antimalarial Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Artemisinin Antimalarial Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Artemisinin Antimalarial Drugs Market Size by Region
9.3.1 Asia-Pacific Artemisinin Antimalarial Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Artemisinin Antimalarial Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Artemisinin Antimalarial Drugs Sales by Type (2017-2028)
10.2 South America Artemisinin Antimalarial Drugs Sales by Application (2017-2028)
10.3 South America Artemisinin Antimalarial Drugs Market Size by Country
10.3.1 South America Artemisinin Antimalarial Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Artemisinin Antimalarial Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Artemisinin Antimalarial Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Artemisinin Antimalarial Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Artemisinin Antimalarial Drugs Market Size by Country
11.3.1 Middle East & Africa Artemisinin Antimalarial Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Artemisinin Antimalarial Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Artemisinin Antimalarial Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Artemisinin Antimalarial Drugs
12.3 Artemisinin Antimalarial Drugs Production Process
12.4 Artemisinin Antimalarial Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Artemisinin Antimalarial Drugs Typical Distributors
13.3 Artemisinin Antimalarial Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Artemisinin Antimalarial Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Artemisinin Antimalarial Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Artemisinin Antimalarial Drugs Product and Services
Table 6. Novartis Artemisinin Antimalarial Drugs Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Major Business
Table 9. Sanofi Artemisinin Antimalarial Drugs Product and Services
Table 10. Sanofi Artemisinin Antimalarial Drugs Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Ajanta Basic Information, Manufacturing Base and Competitors
Table 12. Ajanta Major Business
Table 13. Ajanta Artemisinin Antimalarial Drugs Product and Services
Table 14. Ajanta Artemisinin Antimalarial Drugs Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Cipla Basic Information, Manufacturing Base and Competitors
Table 16. Cipla Major Business
Table 17. Cipla Artemisinin Antimalarial Drugs Product and Services
Table 18. Cipla Artemisinin Antimalarial Drugs Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Ipca Basic Information, Manufacturing Base and Competitors
Table 20. Ipca Major Business
Table 21. Ipca Artemisinin Antimalarial Drugs Product and Services
Table 22. Ipca Artemisinin Antimalarial Drugs Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Guilin Medicine Basic Information, Manufacturing Base and Competitors
Table 24. Guilin Medicine Major Business
Table 25. Guilin Medicine Artemisinin Antimalarial Drugs Product and Services
Table 26. Guilin Medicine Artemisinin Antimalarial Drugs Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 28. GlaxoSmithKline Major Business
Table 29. GlaxoSmithKline Artemisinin Antimalarial Drugs Product and Services
Table 30. GlaxoSmithKline Artemisinin Antimalarial Drugs Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Mylan Labs Basic Information, Manufacturing Base and Competitors
Table 32. Mylan Labs Major Business
Table 33. Mylan Labs Artemisinin Antimalarial Drugs Product and Services
Table 34. Mylan Labs Artemisinin Antimalarial Drugs Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Roche Basic Information, Manufacturing Base and Competitors
Table 36. Roche Major Business
Table 37. Roche Artemisinin Antimalarial Drugs Product and Services
Table 38. Roche Artemisinin Antimalarial Drugs Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Artemisinin Antimalarial Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (KG)
Table 40. Global Artemisinin Antimalarial Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Artemisinin Antimalarial Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Artemisinin Antimalarial Drugs Production Capacity by Company, (KG): 2020 VS 2021
Table 43. Head Office and Artemisinin Antimalarial Drugs Production Site of Key Manufacturer
Table 44. Artemisinin Antimalarial Drugs New Entrant and Capacity Expansion Plans
Table 45. Artemisinin Antimalarial Drugs Mergers & Acquisitions in the Past Five Years
Table 46. Global Artemisinin Antimalarial Drugs Sales by Region (2017-2022) & (KG)
Table 47. Global Artemisinin Antimalarial Drugs Sales by Region (2023-2028) & (KG)
Table 48. Global Artemisinin Antimalarial Drugs Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Artemisinin Antimalarial Drugs Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Artemisinin Antimalarial Drugs Sales by Type (2017-2022) & (KG)
Table 51. Global Artemisinin Antimalarial Drugs Sales by Type (2023-2028) & (KG)
Table 52. Global Artemisinin Antimalarial Drugs Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Artemisinin Antimalarial Drugs Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Artemisinin Antimalarial Drugs Price by Type (2017-2022) & (US$/G)
Table 55. Global Artemisinin Antimalarial Drugs Price by Type (2023-2028) & (US$/G)
Table 56. Global Artemisinin Antimalarial Drugs Sales by Application (2017-2022) & (KG)
Table 57. Global Artemisinin Antimalarial Drugs Sales by Application (2023-2028) & (KG)
Table 58. Global Artemisinin Antimalarial Drugs Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Artemisinin Antimalarial Drugs Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Artemisinin Antimalarial Drugs Price by Application (2017-2022) & (US$/G)
Table 61. Global Artemisinin Antimalarial Drugs Price by Application (2023-2028) & (US$/G)
Table 62. North America Artemisinin Antimalarial Drugs Sales by Country (2017-2022) & (KG)
Table 63. North America Artemisinin Antimalarial Drugs Sales by Country (2023-2028) & (KG)
Table 64. North America Artemisinin Antimalarial Drugs Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Artemisinin Antimalarial Drugs Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Artemisinin Antimalarial Drugs Sales by Type (2017-2022) & (KG)
Table 67. North America Artemisinin Antimalarial Drugs Sales by Type (2023-2028) & (KG)
Table 68. North America Artemisinin Antimalarial Drugs Sales by Application (2017-2022) & (KG)
Table 69. North America Artemisinin Antimalarial Drugs Sales by Application (2023-2028) & (KG)
Table 70. Europe Artemisinin Antimalarial Drugs Sales by Country (2017-2022) & (KG)
Table 71. Europe Artemisinin Antimalarial Drugs Sales by Country (2023-2028) & (KG)
Table 72. Europe Artemisinin Antimalarial Drugs Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Artemisinin Antimalarial Drugs Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Artemisinin Antimalarial Drugs Sales by Type (2017-2022) & (KG)
Table 75. Europe Artemisinin Antimalarial Drugs Sales by Type (2023-2028) & (KG)
Table 76. Europe Artemisinin Antimalarial Drugs Sales by Application (2017-2022) & (KG)
Table 77. Europe Artemisinin Antimalarial Drugs Sales by Application (2023-2028) & (KG)
Table 78. Asia-Pacific Artemisinin Antimalarial Drugs Sales by Region (2017-2022) & (KG)
Table 79. Asia-Pacific Artemisinin Antimalarial Drugs Sales by Region (2023-2028) & (KG)
Table 80. Asia-Pacific Artemisinin Antimalarial Drugs Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Artemisinin Antimalarial Drugs Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Artemisinin Antimalarial Drugs Sales by Type (2017-2022) & (KG)
Table 83. Asia-Pacific Artemisinin Antimalarial Drugs Sales by Type (2023-2028) & (KG)
Table 84. Asia-Pacific Artemisinin Antimalarial Drugs Sales by Application (2017-2022) & (KG)
Table 85. Asia-Pacific Artemisinin Antimalarial Drugs Sales by Application (2023-2028) & (KG)
Table 86. South America Artemisinin Antimalarial Drugs Sales by Country (2017-2022) & (KG)
Table 87. South America Artemisinin Antimalarial Drugs Sales by Country (2023-2028) & (KG)
Table 88. South America Artemisinin Antimalarial Drugs Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Artemisinin Antimalarial Drugs Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Artemisinin Antimalarial Drugs Sales by Type (2017-2022) & (KG)
Table 91. South America Artemisinin Antimalarial Drugs Sales by Type (2023-2028) & (KG)
Table 92. South America Artemisinin Antimalarial Drugs Sales by Application (2017-2022) & (KG)
Table 93. South America Artemisinin Antimalarial Drugs Sales by Application (2023-2028) & (KG)
Table 94. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Region (2017-2022) & (KG)
Table 95. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Region (2023-2028) & (KG)
Table 96. Middle East & Africa Artemisinin Antimalarial Drugs Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Artemisinin Antimalarial Drugs Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Type (2017-2022) & (KG)
Table 99. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Type (2023-2028) & (KG)
Table 100. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Application (2017-2022) & (KG)
Table 101. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Application (2023-2028) & (KG)
Table 102. Artemisinin Antimalarial Drugs Raw Material
Table 103. Key Manufacturers of Artemisinin Antimalarial Drugs Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Artemisinin Antimalarial Drugs Typical Distributors
Table 107. Artemisinin Antimalarial Drugs Typical Customers
List of Figures
Figure 1. Artemisinin Antimalarial Drugs Picture
Figure 2. Global Artemisinin Antimalarial Drugs Revenue Market Share by Type in 2021
Figure 3. Artesunate
Figure 4. Dihydroartemisinin
Figure 5. Artemether
Figure 6. Global Artemisinin Antimalarial Drugs Revenue Market Share by Application in 2021
Figure 7. Prevention
Figure 8. Treatment
Figure 9. Other
Figure 10. Global Artemisinin Antimalarial Drugs Revenue, (USD Million) & (KG): 2017 & 2021 & 2028
Figure 11. Global Artemisinin Antimalarial Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Artemisinin Antimalarial Drugs Sales (2017-2028) & (KG)
Figure 13. Global Artemisinin Antimalarial Drugs Price (2017-2028) & (US$/G)
Figure 14. Global Artemisinin Antimalarial Drugs Production Capacity (2017-2028) & (KG)
Figure 15. Global Artemisinin Antimalarial Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Artemisinin Antimalarial Drugs Market Drivers
Figure 17. Artemisinin Antimalarial Drugs Market Restraints
Figure 18. Artemisinin Antimalarial Drugs Market Trends
Figure 19. Global Artemisinin Antimalarial Drugs Sales Market Share by Manufacturer in 2021
Figure 20. Global Artemisinin Antimalarial Drugs Revenue Market Share by Manufacturer in 2021
Figure 21. Artemisinin Antimalarial Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Artemisinin Antimalarial Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Artemisinin Antimalarial Drugs Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Artemisinin Antimalarial Drugs Sales Market Share by Region (2017-2028)
Figure 25. Global Artemisinin Antimalarial Drugs Revenue Market Share by Region (2017-2028)
Figure 26. North America Artemisinin Antimalarial Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Europe Artemisinin Antimalarial Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Artemisinin Antimalarial Drugs Revenue (2017-2028) & (USD Million)
Figure 29. South America Artemisinin Antimalarial Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Artemisinin Antimalarial Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Global Artemisinin Antimalarial Drugs Sales Market Share by Type (2017-2028)
Figure 32. Global Artemisinin Antimalarial Drugs Revenue Market Share by Type (2017-2028)
Figure 33. Global Artemisinin Antimalarial Drugs Price by Type (2017-2028) & (US$/G)
Figure 34. Global Artemisinin Antimalarial Drugs Sales Market Share by Application (2017-2028)
Figure 35. Global Artemisinin Antimalarial Drugs Revenue Market Share by Application (2017-2028)
Figure 36. Global Artemisinin Antimalarial Drugs Price by Application (2017-2028) & (US$/G)
Figure 37. North America Artemisinin Antimalarial Drugs Sales Market Share by Type (2017-2028)
Figure 38. North America Artemisinin Antimalarial Drugs Sales Market Share by Application (2017-2028)
Figure 39. North America Artemisinin Antimalarial Drugs Sales Market Share by Country (2017-2028)
Figure 40. North America Artemisinin Antimalarial Drugs Revenue Market Share by Country (2017-2028)
Figure 41. United States Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Artemisinin Antimalarial Drugs Sales Market Share by Type (2017-2028)
Figure 45. Europe Artemisinin Antimalarial Drugs Sales Market Share by Application (2017-2028)
Figure 46. Europe Artemisinin Antimalarial Drugs Sales Market Share by Country (2017-2028)
Figure 47. Europe Artemisinin Antimalarial Drugs Revenue Market Share by Country (2017-2028)
Figure 48. Germany Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Artemisinin Antimalarial Drugs Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Artemisinin Antimalarial Drugs Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Artemisinin Antimalarial Drugs Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Artemisinin Antimalarial Drugs Revenue Market Share by Region (2017-2028)
Figure 57. China Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Artemisinin Antimalarial Drugs Sales Market Share by Type (2017-2028)
Figure 64. South America Artemisinin Antimalarial Drugs Sales Market Share by Application (2017-2028)
Figure 65. South America Artemisinin Antimalarial Drugs Sales Market Share by Country (2017-2028)
Figure 66. South America Artemisinin Antimalarial Drugs Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Artemisinin Antimalarial Drugs Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Artemisinin Antimalarial Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Artemisinin Antimalarial Drugs in 2021
Figure 78. Manufacturing Process Analysis of Artemisinin Antimalarial Drugs
Figure 79. Artemisinin Antimalarial Drugs Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
